. 2023 Nov 21;36:101582. doi: 10.1016/j.bbrep.2023.101582

Table 1.

Micromorphological quantitative assay of liver sections.

Experimental Groups N = 6	Hydropic Degeneration^a (Mean %)^b	Fatty Degeneration^a (Mean %)^b	Vascular Congestion^a (Mean %)^b	Inflammatory Cells^a (Mean %)^b	Lesion Scoring (0–100 %)	Lesion Grading
(G1) NCG^c	5.37 %^A#	3.21 %^A	6.42 %^A	2.81 %^A#	0–10 %	No lesion
(G2) PCG (DOX)	92.78 %^E	84.39 %^E	79.62 %^E	76.48 %^E	75–100 %	Critical
(G3) BZF + DOX	75.61 %^D	69.56 %^D	70.85 %^D	74.55 %^D	50–75 %	Severe
(G4) GKB + DOX	71.64 %^D	70.94 %^D	74.61 %^D	62.56 %^D	50–75 %	Severe
(G5) BZF + GKB + DOX	50.69 %^C	49.72 %^C	53.82 %^C	48.51 %^C	25–50 %	Moderate

Notes.

#Statistical comparison among groups: Mean values with different capital letters have significant differences at (P < 0.05).

Hepatocytes hydropic degeneration, fatty degeneration and inflammatory cells were estimated in (%) of cell numbers. Area of vascular congestion estimated in mean percentage of (μm).

Each value represents the mean percentage (n = 6).

G1: Negative control group (NCG), Distilled water; G2: Positive control group (PCG), Doxorubicin (DOX) 3.6 mg/kg; G3: Bezafibrate (BZF) group 100 mg/kg with DOX; G4: Ginkgo biloba (GKB) group 60 mg/kg with DOX; G5: Bezafibrate 100 mg/kg and Ginkgo biloba 60 mg/kg with DOX.